Perlegen and Merck to Work on Whole-Genome Analysis
News Oct 05, 2005
Perlegen Sciences, Inc. has announced that it will assist Merck & Co., Inc. in conducting a high-density whole genome analysis of 1,000 individuals with important clinical characteristics.
Using Affymetrix GeneChip® technology including the GeneChip® Human Mapping 500K Array Set, Perlegen scientists will assay up to 675,000 genetic variations (also called single nucleotide polymorphisms or SNPs) in DNA samples provided by Merck.
Perlegen will utilize its high capacity SNP genotyping capability to rapidly generate extremely dense DNA variation data that can be integrated with other large datasets Merck has generated by molecular profiling clinically important tissue samples internally.
“We are pleased to work with Merck scientists in identifying DNA variations that may underlie biological mechanisms important to their drug discovery efforts,” Brad Margus, CEO of Perlegen.
“It was an honor to have been selected by Merck for this important project.”
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018